-
Product Insights
NewEsophageal Diseases – Drugs In Development, 2024
Empower your strategies with our Esophageal Diseases – Drugs In Development, 2024 report and make more profitable business decisions. Esophageal Diseases, which are characterized by weakened muscles and narrowing of the esophageal opening, often lead to difficulties in digestion and swallowing. The esophagus is the tube-shaped muscle that connects the throat to the stomach. Esophageal diseases occur when the esophagus muscle and opening become weak. The most common problem with the esophagus is GERD (gastroesophageal reflux disease). With GERD, a muscle...
-
Product Insights
NewEsophagitis – Drugs In Development, 2024
Empower your strategies with our Esophagitis – Drugs In Development, 2024 report and make more profitable business decisions. Esophagitis is inflammation of the esophagus, often triggered by acid reflux, infections, medications, or allergies. Symptoms include painful swallowing, heartburn, chest pain, and sometimes bleeding. Common types include reflux esophagitis (due to GERD) and infectious esophagitis (caused by viruses, fungi, or bacteria). Diagnosis involves endoscopy and sometimes imaging tests. Treatment focuses on addressing the underlying cause, using acid-suppressing medications, antibiotics, antifungals, or lifestyle...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TR-8 in Multiple Sclerosis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.TR-8 in Multiple Sclerosis Drug Details:TR-8 is under development for the treatment of Crohn's disease and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ceclazepide in Pancreatic Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ceclazepide in Pancreatic Cancer Drug Details:Ceclazepide (TR-2A) is under development for the treatment of gastro-oesophageal reflux...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ceclazepide in Gastric Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ceclazepide in Gastric Cancer Drug Details:Ceclazepide (TR-2A) is under development for the treatment of gastro-oesophageal reflux...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ceclazepide in Reflux Esophagitis (Gastroesophageal Reflux Disease)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ceclazepide in Reflux Esophagitis (Gastroesophageal Reflux Disease) Drug Details:Ceclazepide (TR-2A) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ceclazepide in Barretts Esophagus
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Ceclazepide in Barretts EsophagusDrug Details:Ceclazepide (TR-2A) is under development for the treatment of gastro-oesophageal reflux disease,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PL-3994 in Diastolic Heart Failure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PL-3994 in Diastolic Heart Failure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PL-3994 in Diastolic Heart FailureDrug Details:PL-3994 is under development for the treatment...
-
Product Insights
Renal Denervation Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Renal Denervation Catheters Pipeline Market Report Overview Renal denervation is also known as renal sympathetic denervation (RSD). It is a minimally invasive, catheter-based endovascular procedure that utilizes radiofrequency energy or ultrasound energy to ablate nerves in the walls of the renal artery, causing a reduction in nerve activity which ultimately reduces the blood pressure in patients with resistant hypertension. The Renal Denervation Catheters pipeline market research report provides comprehensive information about the Renal Denervation Catheters pipeline products with a comparative...
-
Product Insights
Structural Heart Occluders Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Structural Heart Occluders Pipeline Market Report Overview Structural heart occluders are used for the treatment of congenital heart defects by closing openings in the heart. Structural heart occluders cover left atrial appendage closure devices, atrial septal defect occluders, ventricular septal defect occluders, patent foramen ovale closure devices, and patent ductus arteriosus closure devices. The structural heart occluders pipeline market research report provides comprehensive information about the structural heart occluders pipeline products with a comparative analysis of the products at various...